137 related articles for article (PubMed ID: 19223869)
1. Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptor.
Mukherjee A; Narayan KP; Pal K; Kumar JM; Rangaraj N; Kalivendi SV; Banerjee R
Mol Ther; 2009 Apr; 17(4):623-31. PubMed ID: 19223869
[TBL] [Abstract][Full Text] [Related]
2. Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect.
Pore SK; Choudhary A; Rathore B; Ganguly A; Sujitha P; Kumar CG; Agawane SB; Kumar JM; Scaria V; Pillai B; Banerjee R
Biomaterials; 2013 Sep; 34(28):6804-17. PubMed ID: 23773821
[TBL] [Abstract][Full Text] [Related]
3. Assessment of glucocorticoid receptor-heat shock protein 90 interactions in vivo during nucleocytoplasmic trafficking.
Yang J; DeFranco DB
Mol Endocrinol; 1996 Jan; 10(1):3-13. PubMed ID: 8838140
[TBL] [Abstract][Full Text] [Related]
4. Differential alteration of heat shock protein 90 in mice modifies glucocorticoid receptor function and susceptibility to trauma.
Shen HY; Zhao Y; Chen XY; Xiong RP; Lu JL; Chen JF; Chen LY; Zhou YG
J Neurotrauma; 2010 Feb; 27(2):373-81. PubMed ID: 19845467
[TBL] [Abstract][Full Text] [Related]
5. Hsp90 inhibitors attenuate effect of dexamethasone on activated NF-kappaB and AP-1.
Tago K; Tsukahara F; Naruse M; Yoshioka T; Takano K
Life Sci; 2004 Mar; 74(16):1981-92. PubMed ID: 14967193
[TBL] [Abstract][Full Text] [Related]
6. In vivo evidence for the generation of a glucocorticoid receptor-heat shock protein-90 complex incapable of binding hormone by the calmodulin antagonist phenoxybenzamine.
Ning YM; Sánchez ER
Mol Endocrinol; 1996 Jan; 10(1):14-23. PubMed ID: 8838141
[TBL] [Abstract][Full Text] [Related]
7. Regulation of nuclear retention of glucocorticoid receptor by nuclear Hsp90.
Tago K; Tsukahara F; Naruse M; Yoshioka T; Takano K
Mol Cell Endocrinol; 2004 Jan; 213(2):131-8. PubMed ID: 15062560
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin.
Bamberger CM; Wald M; Bamberger AM; Schulte HM
Mol Cell Endocrinol; 1997 Aug; 131(2):233-40. PubMed ID: 9296382
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of heat shock transcription factor by GR.
Wadekar SA; Li D; Periyasamy S; Sánchez ER
Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer.
Jinka S; Rachamalla HK; Bhattacharyya T; Sridharan K; Sekhar Jaggarapu MMC; Yakati V; Banerjee R
Biomed Mater; 2021 Feb; 16(2):024105. PubMed ID: 33434900
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds.
Prima V; Depoix C; Masselot B; Formstecher P; Lefebvre P
J Steroid Biochem Mol Biol; 2000; 72(1-2):1-12. PubMed ID: 10731632
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors.
Mondal SK; Jinka S; Pal K; Nelli S; Dutta SK; Wang E; Ahmad A; AlKharfy KM; Mukhopadhyay D; Banerjee R
Mol Pharm; 2016 Jul; 13(7):2507-23. PubMed ID: 27184196
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the glucocorticoid receptor assembly with heat shock protein 90 by a peptidic antiglucocorticoid.
Dao-Phan HP; Formstecher P; Lefebvre P
Mol Endocrinol; 1997 Jun; 11(7):962-72. PubMed ID: 9178755
[TBL] [Abstract][Full Text] [Related]
14. Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity: cortivazol is a specific ligand for the glucocorticoid receptor.
Yoshikawa N; Makino Y; Okamoto K; Morimoto C; Makino I; Tanaka H
J Biol Chem; 2002 Feb; 277(7):5529-40. PubMed ID: 11741935
[TBL] [Abstract][Full Text] [Related]
15. α Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes.
Zhao X; Khurana S; Charkraborty S; Tian Y; Sedor JR; Bruggman LA; Kao HY
J Biol Chem; 2017 Feb; 292(5):1637-1647. PubMed ID: 27998979
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton.
Galigniana MD; Scruggs JL; Herrington J; Welsh MJ; Carter-Su C; Housley PR; Pratt WB
Mol Endocrinol; 1998 Dec; 12(12):1903-13. PubMed ID: 9849964
[TBL] [Abstract][Full Text] [Related]
17. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells.
Whitesell L; Cook P
Mol Endocrinol; 1996 Jun; 10(6):705-12. PubMed ID: 8776730
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of heat shock factor activity prevents heat shock potentiation of glucocorticoid receptor-mediated gene expression.
Li DP; Li Calzi S; Sánchez ER
Cell Stress Chaperones; 1999 Dec; 4(4):223-34. PubMed ID: 10590836
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of stress resilience through histone deacetylase 6-mediated regulation of glucocorticoid receptor chaperone dynamics.
Jochems J; Teegarden SL; Chen Y; Boulden J; Challis C; Ben-Dor GA; Kim SF; Berton O
Biol Psychiatry; 2015 Feb; 77(4):345-55. PubMed ID: 25442004
[TBL] [Abstract][Full Text] [Related]
20. Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression.
Ide H; Inoue S; Mizushima T; Kashiwagi E; Zheng Y; Miyamoto H
Mol Carcinog; 2019 Dec; 58(12):2297-2305. PubMed ID: 31535408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
